Get started
RocketTickers

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the

Long
Karyopharm Therapeutics Inc. (NASDAQ:KPTI)  
RocketTickers  
NASDAQ:KPTI   Karyopharm Therapeutics Inc.
Beyond Technical Analysis
3
1
beyondta
KPTI: Karyopharm Therapeutics Inc.
2020-06-22 11:25:10
Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.